TN2013000429A1 - Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity - Google Patents
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityInfo
- Publication number
- TN2013000429A1 TN2013000429A1 TNP2013000429A TN2013000429A TN2013000429A1 TN 2013000429 A1 TN2013000429 A1 TN 2013000429A1 TN P2013000429 A TNP2013000429 A TN P2013000429A TN 2013000429 A TN2013000429 A TN 2013000429A TN 2013000429 A1 TN2013000429 A1 TN 2013000429A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- agonist activity
- beta2 adrenergic
- adrenergic receptor
- receptor antagonist
- Prior art date
Links
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 title abstract 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- 239000000048 adrenergic agonist Substances 0.000 title abstract 2
- 229940126157 adrenergic receptor agonist Drugs 0.000 title abstract 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to compounds acting both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists, to processes for their preparation, to compositions comprising them, to therapeutic uses and combinations with other pharmaceutical active ingredients.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12165283 | 2012-04-24 | ||
| PCT/EP2012/060795 WO2012168359A1 (en) | 2011-06-10 | 2012-06-07 | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000429A1 true TN2013000429A1 (en) | 2015-03-30 |
Family
ID=54359586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000429A TN2013000429A1 (en) | 2012-04-24 | 2013-10-18 | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000429A1 (en) |
-
2013
- 2013-10-18 TN TNP2013000429A patent/TN2013000429A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG195375A1 (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| PH12015501247A1 (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| PH12017501424A1 (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| BR112015012746A2 (en) | compounds having muscarinic receptor antagonist and beta2-adrenergic receptor agonist activity | |
| EP4268814A3 (en) | Pharmaceutical composition for the treatment of dry eye | |
| MX2012012897A (en) | New cyclohexylamine derivatives having î²2 adrenergic agonist and m3 muscarinic antagonist activities. | |
| HK1197240A1 (en) | New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities | |
| PH12013501136A1 (en) | Lysophosphatidic acid receptor antagonists and uses thereof | |
| HUE039931T2 (en) | Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent | |
| PH12014501056A1 (en) | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities | |
| PH12015501398A1 (en) | New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity | |
| MX376160B (en) | COMPOUNDS THAT HAVE MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY. | |
| TN2013000429A1 (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| UA109581C2 (en) | COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS | |
| UA96048C2 (en) | Use of interleukin-1 receptor antagonist as an frigoprotective agent |